Client Result
Orrick Advises Solis on Investment in User Research
January.06.2020
January.06.2020
February.24.2020
March.04.2020
June.25.2020
June.25.2020
February.10.2020
June.08.2020
Orrick has advised San Francisco-based synthetic biology company Twist Bioscience (NASDAQ: TWST) on its $107.4 million follow-on offering.
June.12.2020
June.04.2020
June.18.2020
June.15.2020
June.30.2020